Comprehensive Genetic Analysis for Lifelong Health Management
Conducting a broad initial genetic analysis provides individuals with a lifelong resource. In the future, if a genetically influenced condition arises, this data can often be reanalyzed to establish a diagnosis or support treatment decisions within hours or days—without the need for additional testing.
This Panel Offers:
-
Identification of treatable diseases with personalized treatment options
-
Detection of drug sensitivities and data for personalized dosage adjustments
-
HLA typing to assess risks for autoimmune diseases
-
Risk analysis for polygenic diseases inherited through multiple genes, projected to become increasingly relevant in the next 1–2 years
Tests to Be Performed
-
Whole Genome Sequencing (WGS)
-
Mitochondrial DNA Sequence Analysis
Who Can Take the Test?
-
The general population
Number of Genes Analyzed
-
10,000+
Assessments Based on Gene Analysis
-
All-inclusive genetic risk assessment panels
-
Clinical evaluation based on the individual’s current or future symptoms
-
Pharmacogenetic analysis for drug dosing and risk evaluation
-
Analysis of HLA-associated diseases
